Whole Cell Pertussis: Clinical Trials

2 trials for Whole Cell Pertussis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow Whole Cell Pertussis: new trials by email Literature Review of Whole Cell Pertussis trials Research Report on Whole Cell Pertussis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate the Immunogenicity and Reactogenicity of a Booster Dose of GSK2036874A Vaccine in Healthy Toddlers
GSK2036874A vaccine, Zilbrix™/Hib vaccine, Poliorix™ - Haemophilus Influenzae Type b, Tetanus
Phase 2CompletedGlaxoSmithKline3122010-05-132019-10-01
A Study to Assess Antibody Persistence, Boostability & Safety in Previously Primed Subjects.
DTPw-HBV/Hib-MenAC conjugate vaccine - Haemophilus Influenzae Type b, Tetanus
Phase 2CompletedGlaxoSmithKline4502003-07-012016-09-09

Narrower conditions

Diphtheria (2)  ·  Haemophilus Infections (2)  ·  Hepatitis B (2)  ·  Tetanus (2)

Broader conditions

Actinomycetales Infections (2)  ·  Bacterial Infections (2)  ·  Bacterial Infections and Mycoses (2)  ·  Blood-Borne Infections (2)  ·  Clostridium Infections (2)  ·  Communicable Diseases (2)  ·  Corynebacterium Infections (2)  ·  DNA Virus Infections (2)  ·  Digestive System Diseases (2)  ·  Gram-Negative Bacterial Infections (2)  ·  Gram-Positive Bacterial Infections (2)  ·  Hepadnaviridae Infections (2)  ·  Hepatitis (2)  ·  Hepatitis, Viral, Human (2)  ·  Infections (2)

Sponsors

GlaxoSmithKline (2)

Countries

Philippines (2)

NIH funding

2016 (1)